全文获取类型
收费全文 | 10109963篇 |
免费 | 630373篇 |
国内免费 | 161292篇 |
专业分类
耳鼻咽喉 | 130782篇 |
儿科学 | 282436篇 |
妇产科学 | 231777篇 |
基础医学 | 1253959篇 |
口腔科学 | 264457篇 |
临床医学 | 1022666篇 |
内科学 | 1697532篇 |
皮肤病学 | 203714篇 |
神经病学 | 730482篇 |
特种医学 | 377195篇 |
外国民族医学 | 1661篇 |
外科学 | 1330763篇 |
综合类 | 706413篇 |
现状与发展 | 513篇 |
一般理论 | 3725篇 |
预防医学 | 811561篇 |
眼科学 | 230485篇 |
药学 | 864867篇 |
2778篇 | |
中国医学 | 209994篇 |
肿瘤学 | 543868篇 |
出版年
2023年 | 53709篇 |
2022年 | 131432篇 |
2021年 | 200419篇 |
2020年 | 143198篇 |
2019年 | 146069篇 |
2018年 | 178133篇 |
2017年 | 158468篇 |
2016年 | 152519篇 |
2015年 | 189381篇 |
2014年 | 277359篇 |
2013年 | 369306篇 |
2012年 | 522028篇 |
2011年 | 566139篇 |
2010年 | 383527篇 |
2009年 | 345092篇 |
2008年 | 482177篇 |
2007年 | 502524篇 |
2006年 | 479699篇 |
2005年 | 441716篇 |
2004年 | 388660篇 |
2003年 | 360307篇 |
2002年 | 332187篇 |
2001年 | 312279篇 |
2000年 | 310818篇 |
1999年 | 266265篇 |
1998年 | 111161篇 |
1997年 | 97700篇 |
1996年 | 91683篇 |
1995年 | 83761篇 |
1994年 | 75923篇 |
1993年 | 64910篇 |
1992年 | 182891篇 |
1991年 | 176930篇 |
1990年 | 171638篇 |
1989年 | 166581篇 |
1988年 | 154002篇 |
1987年 | 150087篇 |
1986年 | 142890篇 |
1985年 | 136143篇 |
1984年 | 103676篇 |
1983年 | 89010篇 |
1982年 | 56702篇 |
1979年 | 93071篇 |
1978年 | 66796篇 |
1977年 | 57598篇 |
1975年 | 58441篇 |
1974年 | 67411篇 |
1973年 | 64320篇 |
1972年 | 59454篇 |
1971年 | 55075篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
1.
2.
3.
Collagens are the most abundant proteins in the extracellular matrix. They provide a framework to build organs and tissues and give structural support to make them resistant to mechanical load and forces. Several intra‐ and extracellular modifications are needed to make functional collagen molecules, intracellular post‐translational modifications of proline and lysine residues having key roles in this. In this article, we provide a review on the enzymes responsible for the proline and lysine modifications, that is collagen prolyl 4‐hydroxylases, 3‐hydroxylases and lysyl hydroxylases, and discuss their biological functions and involvement in diseases. 相似文献
4.
Mette Nissen Tiina‐Mari Ikheimo Jukka Huttunen Ville Leinonen Henna‐Kaisa Jyrkknen Mikael von und zu Fraunberg 《Neuromodulation》2021,24(1):102-111
ObjectiveSpinal cord stimulation (SCS) is an effective treatment in failed back surgery syndrome (FBSS). We studied the effect of preimplantation opioid use on SCS outcome and the effect of SCS on opioid use during a two-year follow-up period.Materials and methodsThe study cohort included 211 consecutive FBSS patients who underwent an SCS trial from January 1997 to March 2014. Participants were divided into groups, which were as follows: 1) SCS trial only (n = 47), 2) successful SCS (implanted and in use throughout the two-year follow-up period, n = 131), and 3) unsuccessful SCS (implanted but later explanted or revised due to inadequate pain relief, n = 29). Patients who underwent explantation for other reasons (n = 4) were excluded. Opioid purchase data from January 1995 to March 2016 were retrieved from national registries.ResultsHigher preimplantation opioid doses associated with unsuccessful SCS (ROC: AUC = 0.66, p = 0.009), with 35 morphine milligram equivalents (MME)/day as the optimal cutoff value. All opioids were discontinued in 23% of patients with successful SCS, but in none of the patients with unsuccessful SCS (p = 0.004). Strong opioids were discontinued in 39% of patients with successful SCS, but in none of the patients with unsuccessful SCS (p = 0.04). Mean opioid dose escalated from 18 ± 4 MME/day to 36 ± 6 MME/day with successful SCS and from 22 ± 8 MME/day to 82 ± 21 MME/day with unsuccessful SCS (p < 0.001).ConclusionsHigher preimplantation opioid doses were associated with SCS failure, suggesting the need for opioid tapering before implantation. With continuous SCS therapy and no explantation or revision due to inadequate pain relief, 39% of FBSS patients discontinued strong opioids, and 23% discontinued all opioids. This indicates that SCS should be considered before detrimental dose escalation. 相似文献
5.
6.
7.
8.
Behzad Emadi Mojtaba Ghahraman Rezaieh Mansour Sedighi 《Transfusion and apheresis science》2021,60(3):103132
Transfusion transmissible infections (TTIs) have been a public health challenge for the accessibility, quality and safety of blood transfusion. The present study aimed to consider the prevalence and the trends of hepatitis B virus (HBV), hepatitis C virus (HCV), Human T-cell leukemia virus type 1 (HTLV-1), human immunodeficiency virus (HIV) and syphilis across the ten years among retrospective blood donors. A retrospective investigation of blood donors’ data covering the period from 22 May 2009 to 22 May 2019 was done. Data was accumulated and analyzed from Blood Transfusion Center records, pertaining to all donors who were screened for various TTIs using respective immunological techniques. Out of the 682,171 screened donors in the 2009–2019 study period, 2470 (0.36 %) were infected with at least one infectious agent. The overall prevalence of HBV, HCV, HTLV-1, HIV and syphilis were 1700 (0.25 %), 184 (0.027 %), 335 (0.05 %), 4 (0.0.05 %) and 247 (0.036 %), respectively. The study showed male dominated donor pool (96.79 %) with higher prevalence (0.34 %) of TTIs compared to female donors (0.02 %) with 3.21 % population. Despite the low prevalence of TTIs in our study, HBV, HCV, syphilis and HIV have remained a big threat to safe blood transfusion in Iran. Strict adherence to selection criteria, algorithm of donor screening, use of highly sensitive and specific methods for detection of TTIs, regular consultation and health education programs, prevention and sanitization strategies to reduce the risk of TTIs are recommended to reduce the risk of TTIs and ensure the safety of blood transfusion for recipient. 相似文献
9.
10.
Qian Zhang Larry D. Mesner Gina M. Calabrese Naomi Dirckx Zhu Li Angela Verardo Qian Yang Robert J. Tower Marie-Claude Faugere Charles R. Farber Thomas L. Clemens 《The Journal of clinical investigation》2021,131(7)
Bone mineral density (BMD) is a highly heritable predictor of osteoporotic fracture. GWAS have identified hundreds of loci influencing BMD, but few have been functionally analyzed. In this study, we show that SNPs within a BMD locus on chromosome 14q32.32 alter splicing and expression of PAR-1a/microtubule affinity regulating kinase 3 (MARK3), a conserved serine/threonine kinase known to regulate bioenergetics, cell division, and polarity. Mice lacking Mark3 either globally or selectively in osteoblasts have increased bone mass at maturity. RNA profiling from Mark3-deficient osteoblasts suggested changes in the expression of components of the Notch signaling pathway. Mark3-deficient osteoblasts exhibited greater matrix mineralization compared with controls that was accompanied by reduced Jag1/Hes1 expression and diminished downstream JNK signaling. Overexpression of Jag1 in Mark3-deficient osteoblasts both in vitro and in vivo normalized mineralization capacity and bone mass, respectively. Together, these findings reveal a mechanism whereby genetically regulated alterations in Mark3 expression perturb cell signaling in osteoblasts to influence bone mass. 相似文献